-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Boston Scientific, Lowers Price Target to $85

Benzinga·07/13/2026 14:14:14
Listen to the news
RBC Capital analyst Shagun Singh maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers the price target from $100 to $85.